Cognitive impairments after critical illness. Methodology, incidences and consequences by Torgersen, Johan
Cognitive impairments after 
critical illness 
Methodology, incidences and consequences 
Johan Torgersen 
 
Dissertation for the degree philosophiae doctor (PhD)  
University of Bergen 
2011 
 
 
 2 
Scientific environment  
The Research Group on Intensive Care Outcome was formally created in 1999 by 
professor dr. med. Hans Flaatten and is situated in the Intensive Care Unit at 
Haukeland University Hospital and at the Department of Surgical Sciences, 
University of Bergen. The main focus is clinical research within the field of outcome 
in survivors after intensive care, but has also focused on quality assurance within 
intensive care.  
Two dissertations have been produced from the group. In 2004 dr. med. Reidar Kvåle 
defended his thesis ”Long-term outcomes after intensive care” and dr. med. Atle 
Ulvik defended his ”Long-term outcomes after major trauma” in 2008. In 2011 cand. 
med. Kristian Strand at Stavanger University Hospital completed his PhD project on 
comparison of two different prognostic scoring models in ICU patients. Norwegian 
Registry of Intensive care (NIR) was established 1998, and has since 2004 been 
adopted and funded by Helse Vest (Governmental institution) as a National Quality 
Registry. The registry is lead by dr. med. Reidar Kvåle. Our ICU have for 10 years 
had a specially designed registry of adverse events. This registry now holds more 
than 3000 adverse events, and there is an ongoing research toward the epidemiology 
of such events in the ICU. 
Our research group is internationally engaged in a study on the effect of an ICU diary 
on post traumatic stress disorder (PTSD) after intensive care. This project is a part of 
a European metacentre study, lead by the University of Liverpool. The so called 
RACHEL group consists of 8-10 ICUs in UK, Sweden, Norway, Italy and Portugal, 
and has previously collaborated in the field of outcome after ICU. The RACHEL 
group is led by Professor Richard Griffiths and Christina Jones (Research nurse) at 
the University of Liverpool. The main focus has been the development of PTSD in 
former ICU patients, and how to reduce this burden. 
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AC  Arachnoid cyst 
APACHE II Acute physiology and chronic health evaluation II 
ARDS Acute respiratory distress syndrome   
CA   Cardiac arrest 
CAM-ICU Confusion assessment method in the intensive care unit 
CANTAB Cambridge Neuropsychological Test Automated Battery 
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SOC  Stockings of Cambridge 
SOFA  Sequential organ failure assessment  
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Introduction 
“But if life itself is good and pleasant (...) and if one who sees is conscious that he 
sees, one who hears that he hears, one who walks that he walks and similarly for all 
the other human activities there is a faculty that is conscious of their exercise, so that 
whenever we perceive, we are conscious that we perceive, and whenever we think, we 
are conscious that we think, and to be conscious that we are perceiving or thinking is 
to be conscious that we exist...”  
Aristotle (382-322 BC) – Nicomachean Ethics  
 
 
Cognitive function is a term used by the psychological and sociological sciences to 
describe abilities emphasized by Aristotle as necessary for human existence: 
Perception and thinking. Research has revealed the complex role of cognitive 
functions in human mental processing. Examples of cognitive functions are short-
time memory, forced decision-making, spatial memory, executive functions, reaction 
time, motor speed and verbal memory. All these functions are involved in one or 
more of the key aspects of cognition: perception, storage, recalling or processing and 
further to use the acquired knowledge.     
Various diseases may affect cognitive functions [1, 2]. At the same time intact 
cognitive functioning is an asset for patients both during illness and rehabilitation. 
During critical illness most patients will experience altered level of cognitive 
performance. This thesis focuses on the effect of critical illness on cognitive 
functions in former intensive care unit patients.  
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Abstract 
Background  
Brain dysfunction describes the wide range of alterations in brain function from 
persistent vegetative state to minor cognitive impairments. It has become evident that 
brain dysfunctions that arise during an intensive care unit (ICU) stay are associated 
with mortality, morbidity, post-ICU functional status and rehabilitation. Brain 
dysfunction in ICU patients is therefore of major interest both in clinical practice and 
research.   
Cognitive impairment is one of several types of brain dysfunctions that may become 
evident after critical illness. The aims of this thesis were to document the incidences 
of cognitive dysfunction after critical illness, to investigate the post-ICU development 
and effects of cognitive functions and, if possible, to point out etiological and 
predisposing factors for such impairment.  
To achieve this, we needed a neuropsychological approach to our patients. We chose 
to use the Cambridge Neuropsychological Test Automated Battery (CANTAB) as our 
method for evaluating cognitive function. CANTAB is a semi-automated 
neuropsychological test battery applied on a laptop PC. The program contains 
integrated normal reference population scores, which facilitate description of the 
tested patients’ level of cognitive function and the statistical handling of the results. 
CANTAB can be administered in an every day setting by non-specialised personnel. 
Main objectives: 
1: To investigate causes and consequences of cognitive impairment in patients 
who have survived critical illness. 
2:  To establish and validate CANTAB for assessing cognitive functions in 
Norwegian hospitalised patients 
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Patients and methods 
In order to establish and validate CANTAB we performed two validation studies in 
two Norwegian patient cohorts. Arachnoid cysts (ACs) are known to cause cognitive 
dysfunction because they compress neighbouring brain tissue; it has also been 
documented that decompression of the cyst improves cognitive functions. We 
investigated if CANTAB could detect the same cognitive improvements after 
decompression of temporal lobe cysts. Reproducing such cognitive improvements 
would establish construct validity of CANTAB. In order to establish criterion validity 
for CANTAB we tested a group of patients with epilepsy who were also tested 
neuropsychologically with a traditional battery, the “gold standard”. In the AC study 
CANTAB was run in parallel mode meaning that we could only compare results from 
before and after testing. Comparison to the integrated reference population can only 
be done with CANTAB in clinical mode as applied on the epilepsy group. Because of 
this we could establish if the epilepsy patients were more cognitively impaired than 
the reference population. This was not possible with the AC patients. 
To evaluate the effect of being critically ill on cognitive function we completed two 
studies on patients who had survived critical illness. Both studies included only 
patients with no pre-ICU increased risk of cognitive dysfunction and who had not 
suffered from primary or secondary cerebral damage before or during ICU stay.  
The first study was on patients who had survived out of hospital cardiac arrest 
(OHCA) with a good functional outcome and who had been treated with therapeutic 
hypothermia. These patients were assessed more than one year after the cardiac arrest 
with CANTAB, Short Form 36 (SF-36) for assessment of health related quality of life 
(HRQOL) and cerebral performance category (CPC) for assessment of functional 
level. 
In the second study we investigated a non-selected group of ICU survivors. Patients 
showing no delirium and with a Mini mental state examination (MMSE) score ≥ 24 at 
ICU discharge were tested with CANTAB immediately and then again after three and 
twelve months. We also gathered information on survival, institutionalisation after 
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hospital discharge, severity of disease, co-morbidity, length of ICU stay and days on 
ventilator support to look for risk factors of cognitive function and possible 
consequences of such impairment.  
Results 
Previous studies have shown that ACs have a predilection for the temporal fossa and 
that they may interfere in a reversible manner with temporal lobe function; thus the 
dyscognition is normalised after a surgical cyst decompression. When testing AC 
patients with a CANTAB battery, we found significant cognitive improvement after 
decompression of the AC in tests that are designed to test for temporal lobe functions. 
However, we found no postoperative improvement in tests that were designed to 
probe frontal lobe functions. These observations establish construct validity of 
CANTAB. 
In the group of patients with epilepsy we found that traditional testing and CANTAB 
testing resulted in the same classification into patients with or without cognitive 
impairment in 12 of 15 patients. Thus, there was an 80% agreement within the two 
tests. In addition several previously documented and clinically logical significant 
correlations were documented when correlating results from the two tests. This 
establishes criterion validity of CANTAB. 
We tested a group of 25 patients who had survived for more than one year after 
cardiac arrest with a good functional outcome (i.e. CPC 1 and 2). The group did not 
differ from a Norwegian reference population in HRQOL. However, 52 % of the 
patients were nevertheless classified with a cognitive dysfunction. 
We included 55 patients in our study on former general ICU patients. Immediately 
after ICU discharge 64% of classifiable patients had cognitive impairments. This 
figure dropped however to 11% and 10% after three and twelve months, respectively. 
We found no associations between pre- or in-ICU factors and the development of 
such impairments. There were no associations between cognitive impairments at 
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discharge from ICU and outcome factors such as mortality, institutionalisation or 
HRQOL. 
Conclusions 
We have for the first time established construct validity and criterion validity of 
CANTAB in Norwegian patients. 
Cognitive impairments are common after cardiac arrest and critical illness. It seems 
that cardiac arrest patients are in higher risk of developing permanent cognitive 
impairments than general ICU patients. We found no associations between ICU-
related cognitive impairments and possible aetiological factors, morbidity, mortality 
or health related quality of life.  
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1. Background 
1.1 Cognition and disease 
1.1.1 Cognition  
Cognition is a term used since the early 1500’s to describe acquired knowledge. Its 
origin is the Latin verb cognoscere meaning “to get acquainted with” or “to get to 
know”. Even though cognition is a word not frequently used in modern English, we 
find the same origin in words like recognition meaning both “to get to know again” 
or “acknowledge” and cognizance meaning “knowledge” or “awareness”. Not 
surprisingly, in science cognition is often described as the “knowledge of knowing”. 
After World War II the term was adopted by the psychological and sociological 
sciences and gained its role as a clinical and scientific term as the modern cognitive 
psychology emerged.  A modern textbook of cognition elaborates and defines 
cognition as: “The acquisition, storage, transformation and use of knowledge” [3].  
The key issue for sciences focusing on cognition and cognitive functions is the 
acquiring of knowledge and aspects of knowledge processing: our ability to perceive 
the world through our senses, our capacity to store information, how we recall 
information, how we process the information both during storage and recollection and 
not at least: how we use the acquired and stored knowledge. After input is delivered 
through our senses the brain conducts all further processing. Numerous functions 
involved both in perception, storage, recalling, transformation, and executing have 
been described and partly located in the brain, but the true nature of cognitive 
functions is not fully revealed. When knowledge is used during tasks of different 
difficulty levels, cognitive functions may display a wide range in performance in the 
same human or between humans. Both brushing our teeth in the morning, driving a 
car, completing a game of chess or intubating a patient demands intact cognitive 
functions directed exactly towards the skill at test.  
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1.1.2 Cognitive psychology 
Cognitive psychology denotes a process-focused approached to psychology. In this 
theoretical orientation a person’s knowledge and the connected mental processes are 
emphasised and used to describe behaviour, skills and function. Cognitive 
psychology can therefore be distinguished from other psychological orientations such 
as behaviourism or the psychodynamic approach. In behaviourism observable 
behaviour is the central aspect. The psychodynamic approach focuses on our 
unconscious emotions when describing behaviour, skills, function and changes in 
these. In contrast, cognitive psychology explores concrete processes such as memory, 
attention, planning, or executive function to describe the same phenomena [3].  
Cognitive psychology leans on several different scientific directions and traditions: 
Philosophy, neuropsychology, neuroscience, artificial intelligence and even more. In 
neuropsychology the focus is on the evaluation of both emotional or psychosocial 
problems and the assessment of cognitive function, where the latter is the core issue. 
The neurosciences focus more on the structures associated with mental processes and 
their location. Examples of such fields of interest are fMRI and neurophysiology that 
can describe areas of the brain involved and neural pathways used when the human 
brain is active. The neuropsychologist evaluates to a larger degree the function and 
use of these structures or pathways during mental processing rather than the 
structures themselves.  
When approaching cognitive functions, the neuropsychologist can choose from a 
wide selection of validated cognitive tests aimed at specific functions. Cognitive tests 
are traditionally administered as pen/paper tests, systematic interviews or by solving 
tasks under observation. The composition of test-batteries, i.e. several tests 
administered together to explore several functions or the same function from different 
views, has proven to be of great advantage. This makes it possible to evaluate intra-
test variability, level of performance and how possible defects appear, thus indicating 
type of brain affection. Further interpretation of these results can give the clinician or 
researcher information about the patient’s cognitive functions and dysfunction [4].  
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These test batteries are in general not validated as a unit; this constitutes a 
methodological problem. On the other hand, single tests are often validated and in 
particular construct validity is established [4]. When establishing construct validity, 
patients with lesions or diseases known to affect particular parts of the brain are 
examined; the resulting deficit can then be assigned to that area of the brain. 
 
1.1.3  Cognition in disease 
It is well documented that many diseases and conditions may affect cognitive 
functions. All patients with primary brain diseases (e.g. brain injury, epilepsy, 
apoplexy) carry the risk of developing cognitive dysfunction at some stage of the 
disease [4-6]. In addition patients with extra-cerebral conditions such as renal failure, 
liver failure or cardiovascular disease also show increased risk of developing 
cognitive dysfunctions, even without any known brain injury [2]. This indicates 
several etiologic causes of cognitive impairment in patients. Primary brain disease 
may cause brain cell dysfunction and death and hence altered cognitive function. 
Other, extra-cerebral diseases may cause reduced brain function for numerous 
reasons. Chronic obstructive pulmonary disease [1] or adult respiratory distress 
syndrome [7] may cause hypoxia, either acute or chronic, which affect brain cell 
function or cause cell death. In other diseases, such as cardiovascular disease, altered 
cerebral perfusion may have the same effects. In patients with renal failure the 
cognitive deterioration may be caused by increased level of circulating metabolites or 
toxins with negative effects on brain cells. The investigation of cognitive function in 
different groups of patients has led us to believe that the development of cognitive 
dysfunction during disease is multifactorial and may be explained by different 
mechanisms.  
Not only are the causes of cognitive dysfunction diverse, so is also the form with 
which the cognitive affection present itself. In cerebral conditions like persistent 
vegetative state, minimally conscious state, delirium or dementia, the patients’ ability 
to acquire, store, transform, or use knowledge is grossly altered, and such patients are 
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markedly cognitively impaired. Patients with no cerebral blood flow above the 
foramen magnum have lost all cognitive function permanently and are considered to 
be dead. When considering patients with severe cerebral damage, the Guidance for 
end of life treatment from Norwegian Health Authorities in fact recommend that 
decisions regarding continuation of treatment or ending treatment can be based on the 
patients expected possibility to acknowledge one-self or be aware of or respond to the 
surroundings [8] . If there is no hope for such awareness, further treatment is regarded 
meaningless. Evaluation of cognitive function is therefore relevant within the full 
range of cerebral functioning and in patients with any kind of cerebral affection. 
 
1.1.4  Critical illness 
Critical illness is defined as a disease or injury with threatening or manifest failure of 
one or more vital organ functions. Intensive care is not only directed towards causal 
diagnosis and treatment, but also the evaluation of organ function and, if necessary, 
organ function support. The main organ systems in intensive care are the respiratory 
system, the circulatory system, the central nervous system (CNS), the kidneys, blood 
homeostasis, and the gastrointestinal tract. The most common primary causes for 
admittance to an intensive care unit (ICU) are respiratory failure, cardiovascular 
failure and severe disease in the CNS [9]. Some of the diseases can strike previous fit 
persons and others primarily affect patients with an underlying disease or organ 
affection. The risk of developing organ dysfunction increases if the organ already 
suffers from disease or is weakened for other reasons. This also applies for disease in 
the CNS. 
The systemic impact of serious disease or trauma may trigger reactions in other 
organs than the ones primary affected. Systemic inflammatory response syndrome 
(SIRS) denotes a condition of vast immunologic activity often triggered by disease 
such as serious infection or major trauma. The inflammatory response may affect 
potentially all organs with a resulting multi-organ dysfunction or failure. All ICU 
patients may therefore ultimately develop multi-organ failure during critical illness. 
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The aetiology of both primary and secondary organ failure is diverse and complex. 
Organ failure may be caused by or cause cellular hypoxia. Patients with respiratory 
failure may transitionally suffer from hypoxemia with resulting cellular hypoxia in 
vulnerable organs. This is an example of primary organ dysfunction (respiratory) with 
secondary dysfunction in other organ systems. Altered cellular activity may 
eventually cause organ dysfunction with clinical relevance.  Renal failure is often 
caused by such hypoxic events. On the other hand, disease in the cardiovascular 
system can cause tissue hypo-perfusion with resulting cellular hypoxia even without 
simultaneous hypoxemia. The reduced detoxification in dysfunctional kidneys may 
cause negative effects on cells in other organs and hence contribute to multiple-organ 
dysfunction.  
 
1.2 General perspectives on the scientific approach to cognitive impairments 
in ICU patients  
1.2.1 Pre-ICU level of cognitive function 
When evaluating cognitive functions in ICU survivors one main challenge arises: we 
often lack knowledge of the patients pre-ICU level of cognitive function. Through a 
thorough anamnesis it is possible to discover severe dysfunction like dementia or 
patients with increased risk of cognitive dysfunctions due to pre-ICU factors, such as 
former stroke or drug/alcohol abuse. When the focus is set on the effects of being 
critically ill, it is possible to exclude such patients aiming for a cohort with 
presumptive cognitively intact individuals. But even so, the normal variation in level 
of cognitive function is wide and in addition a portion of the general population will 
have pre-existing, but not clinically acknowledged dysfunctions. Given the non-
elective nature of most ICU admittances, it is difficult to evaluate the ICU survivors’ 
pre-ICU level of cognitive performance in a way that is directly comparable with the 
results from after-ICU cognitive testing. Regarding the effect of surgery and/or 
general anaesthesia on cognition, it is possible to perform a prospective study, 
measuring the cognitive level before and after surgery to see if there is a 
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postoperative cognitive decline (POCD). As the pre-ICU cognition level is often not 
known, a similar approach is difficult in ICU survivors. Instead of measuring 
cognitive decline, we are confined to classifying the patients as being with or without 
cognitive impairments or comparing them with reference groups [10]. 
 
1.2.2 Description of cognitive level of performance 
The description of cognitive performance after critical illness must rely on either 
comparison with a normal population, a control group or repeated measures in a 
disease specific group. Cognitive functions are regarded as being normally distributed 
in the general population. This enables us to express the former ICU patients’ level of 
cognitive performance relative to the general population or other patients. 
Neuropsychological test batteries are often supplied with such normal reference 
populations making it possible to express the tested patient’s level of cognitive 
performance as an index or even z-scores.  
Z-scores are normalised scores based on the comparison of the patients result with the 
results in a reference population. The z-score equals how many standard deviations 
the results from the patients deviate from the mean score in the reference population. 
A result equal to the mean in the reference population will give a z-score of 0 while 
poorer results will have a negative z-score and better results will have a positive z-
score. Z-scores can be used in classification systems to sort patients into groups of 
impaired or not impaired patients. In a paper by Jackson et al. the authors outline 
several aspects of evaluation of cognitive impairments in ICU survivors [10]. They 
propose the following criteria for categorising a patient with a cognitive impairment: 
At least two out of ten z-scores from neuropsychological testing below -2.0 or at least 
three out of the same ten z-scores below -1.5. This is regarded as rather strict criteria 
for categorising a patient with a cognitive impairment.  
The level of cognitive performance in a test group can be described either by making 
comparison with a normal population or by establishing control groups. When 
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establishing a control group, it is possible to match it to the ICU group. Then it is 
possible to control for several other factors than the ICU survival that may have 
affected cognitive function. 
It is also possible to repeat cognitive testing of a patient over a defined time-period. 
This allows us to investigate the development of cognitive impairment in a time 
perspective. It is possible to categorise patients at each point of time and also to make 
both one-sample group comparison and independent sample group comparison. This 
enables us to establish whether one group of patients has a slower recovery or 
whether specific groups sustain a high incidence of cognitive impairments. 
Given the wide range in level of cerebral performance patients can display after 
critical illness, several tools are often needed to describe all patients in one group. 
Sensitivity and specificity of each tool will vary according to the tested patient’s level 
of performance. MMSE is suitable to address patients with severe cognitive 
impairments while more complex neuropsychological test batteries must be applied if 
subtle changes are to be revealed.  
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2. Study objectives 
This thesis has two main objectives: 
1: Investigate cognitive impairments and their causes and consequences in non-
delirious patients with MMSE ≥ 24 who have survived a period of critical 
illness 
2:  Establish and validate CANTAB for assessing cognitive functions in 
Norwegian hospitalised patients 
To approach the main objectives mentioned above, several aims have been 
formulated: 
1 A: Estimate the incidence of cognitive impairments in a group of ICU survivors 
immediately after ICU discharge 
1 B:  Follow the development of cognitive impairments over the first year after ICU 
discharge 
1 C: Estimate the incidence of cognitive impairments in survivors of out-of-hospital 
cardiac arrest (OHCA) with high functional outcome one year or more after 
the arrest   
1 D: Investigate whether being critically ill affects cognitive function 
1 E: Describe the characteristics of cognitive impairments after critical illness 
1 F: Describe possible pre-ICU or in-ICU predictors of cognitive impairments 
1 G: Investigate the effect of cognitive impairments on mortality, morbidity and 
health related quality of life after ICU discharge 
2 A: Establish and evaluate the practical use of CANTAB in an ICU setting and 
post-ICU setting 
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2 B:  Establish construct validity of CANTAB in a Norwegian hospitalised 
population 
2 C: Establish cross-test validity of CANTAB in a Norwegian hospitalised 
population 
2 D: Establish valid criteria for classification of cognitive impairment in former 
ICU patients based on results from CANTAB 
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3. Patients and methods 
3.1 Patients  
We recruited patients from three hospitals: Haukeland University Hospital (HUH), 
Stavanger University Hospital (SUH) and St. Olav University Hospital (SOUS) in 
Trondheim. HUH is a 1000-bed tertiary referral hospital for about 1 000 000 
inhabitants in Western Norway. The intensive care unit at HUH is a 10-bed 
predominantly surgical (70 %) ICU. Critically ill neonates, burn patients and 
uncomplicated post operative patients after cardiac surgery are treated in separate 
ICUs. In 2009 470 patients were treated in this ICU. All common ICU procedures, 
except ECMO, are performed. All patients in the study on cognitive impairments 
after critical illness were recruited from this ICU. 
From Department of Neurosurgery at HUH we recruited patients for the study on 
ACs. This 27-bed department is a tertiary referral centre for all neurosurgical patients 
in Western Norway and offers all common neurosurgical procedures. In addition, the 
department serves the majority of Norwegian patients with a vestibular schwannoma, 
and all Norwegian patients treated with gamma knife. Some patients with ACs from 
abroad are also referred to the neurosurgical department at HUH for advice or second 
opinion, or even treatment.  
All patients included in the study on epilepsy patients were recruited from 
Department of neurology at HUH. The department serves both as a local hospital for 
about 350 000 patients and as a tertiary referral centre for Western Norway.  
All patients included in the study on cognition after OHCA were recruited from ICUs 
at the SUH and the SOUS.  The SOUS is a tertiary referral centre with a regional 
catchment population of approximately 660 000. The CA patients are recruited from 
both a 10-bed mixed-ICU and an eight-bed coronary care unit.  A total of 1303 
patients were treated in these ICUs in 2008.  
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At SUH all ICU patients needing respiratory support are treated in the same mixed 
medical/surgical ICU including CA patients. This ICU is the only ICU in the hospital 
and has approximately 800 admissions per year. There are 12 beds in the ICU, but 
normal staffing only allows for the use of 7 beds when a nurse patient ratio of 1:1 is 
to be ensured. The ICU at SUH provides intensive care for approximately 320 000 
inhabitants in the southern part of the county of Rogaland.  
 
3.2 Classification of cognitive impairments  
Confusion assessment method in the ICU (CAM-ICU) and Mini-mental state 
examination (MMSE) are both used to diagnose brain dysfunction in ICU patients. 
We used these tools to exclude patients with delirium and MMSE score <24 from our 
studies. Patients with MMSE ≥ 24 were further assessed with CANTAB and were 
classified into having a cognitive impairment or not. A cognitive impairment was 
diagnosed according to Jackson’s criteria after CANTAB assessment. The results 
reported from CANTAB that were used to classify patients are presented in table 6. 
Jackson’s criteria are described in section 1.2.2.  
 
3.3 Cambridge neuropsychological test automated battery (CANTAB)  
3.3.1 General introduction 
By establishing neuropsychological testing we aimed to make neuropsychology a part 
of the scientific and the clinical evaluation of former critically ill patients. When 
assessing cognitive functions in survivors of critical illness, we wanted to apply a 
neuropsychological test that could be administered by the ICU personnel. The test 
battery had to provide us with tests that evaluate cognitive domains often affected 
after critical illness; it should be possible to administer in an ICU setting or in the 
ward and it should produce standardised scores that can be related to a reference 
population. Furthermore, the test battery should be able to provide robust information 
even when available test duration was limited due to the condition of the patients. 
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The range in difficulty level within each test had to be wide ensuring that most 
patients could solve some tasks and few patients could solve all (floor/ceiling 
effects). Traditional neuropsychological testing is usually administered by a specialist 
in neuropsychology, which makes such tests resource demanding. These batteries are 
often complex and time consuming, which make them unsuitable for many of the 
critically ill patients or for those who just has emerged from their critical phase.   
CANTAB is a semi-automated laptop based cognitive test apparatus containing 22 
different cognitive tests. This enables doctors and nurses in the ICU to administer the 
test after a short instruction prior to using. The tests assess cognitive functions within 
the main cognitive domains: Visual memory, semantic/verbal memory, executive 
function, attention and decision making/response control. The automated tests are 
based on traditional cognitive tests developed at the University of Cambridge. With 
CANTAB is possible to compose different test batteries based on the 22 tests 
available to explore the clinical or scientific issue in focus.  All tests are non-verbal, 
consisting of geometric designs or simple shapes and language proficiency is 
necessary only to understand the verbal instructions prior to task initiation. Range in 
difficulty level within each test is wide, thereby reducing both floor and ceiling 
effects. It is also possible to create relevant test batteries, which can be administered 
during 10-15 minutes, thus enabling us to approach exhausted ICU patients as well.  
The tests or test batteries are applied on a laptop with a touch sensitive screen. The 
patient is presented for the different tests on the screen and responds by pressing the 
screen (picture 1).  Both presentation of the tests and the registration of the patient’s 
response on each test are done automatically. This is one of the main advantages of 
such automised testing: inter-tester variability is low. Further the automatic 
registration of results allows for immediate processing and storage in the integrated 
soft-ware. CANTAB contains an integrated English reference population allowing for 
immediate comparison with a group of age and sex matched controls. Cognitive 
functions are regarded normally distributed in the population. Thus each patient’s 
result on each test can be expressed as a z-score by comparing the patient’s raw score 
with the mean raw score in the reference population. This simplifies statistical 
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analysis of the results and categorisation of patients based on recommended criteria 
for such classification.  
CANTAB can be run in to modes: clinical mode or parallel mode. The main feature 
of clinical mode is the comparison of the patient’s results with the reference 
population allowing investigation of the level of cognitive performance for each 
tested patient. In the parallel mode, the main advantage is that the same CANTAB 
test can be run repeatedly, but the content in each test will change, thereby one might 
hope to eliminate or reduce learning effects in the test situation. This mode is eligible 
to follow-up patients where development over a period of time is desirable. In the 
parallel mode comparison with the reference population is not possible.  
 
Picture 1: CANTAB applied on an ICU patient. This patient is dependent on 
respiratory support through a tracheostomy. The test is done bedside and 
accompanied only by the laptop and the investigator 
Some issues arise that have to be addressed before applying CANTAB and 
interpreting the results. Neither CANTAB tests nor the use of its reference population 
has been validated in Norwegian patients. Even though cultural independence is 
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claimed [11] and it is rather unlikely that there are large differences between the 
Norwegian and English normal population, validity had to be established for 
CANTAB also in Norwegian populations. Comparisons with traditional tests are 
sparse, which makes it debatable how CANTAB tests can replace traditional tests. 
CANTAB batteries are suitable for cognitive screening and for research issues, but 
regarding more thorough clinical diagnosing CANTAB has not yet proved its 
equality to traditional testing. Below the tests are described in the order they appear 
during a test session.  
 
3.3.2 Motor Screening test (MOT) 
 
Picture 2: Motor screening test. The 
patient is instructed to press ten 
flashing crosses, appearing one by one, 
as soon as they appear on the screen. 
MOT is an introduction test recommended to use when starting the CANTAB test 
battery. Patients who do not comply with this test are not regarded suitable for further 
CANTAB testing. From MOT it is possible to report speed of response and accuracy 
of pointing. We chose to report speed of response from MOT. 
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3.3.3 Delayed matching to sample (DMS) 
  
 
 
 
Picture 3: Delayed matching to 
sample. The patient is presented with 
one of 30 possible non-figurative 
patterns on the upper half of the 
screen. Subsequently the patients then 
should pick the previously presented 
pattern from four similar patterns 
appearing on the lower half of the 
screen.  The four patterns appear 
either simultaneously or after delays of 
zero, four or twelve seconds. 
DMS is a test for memory and forced decision-making. DMS tests both immediate 
and delayed recognition memory. By comparing results on easy tasks (0 seconds) 
with results from difficult tasks (12 seconds delay) it is possible to differentiate 
between the abilities to store information and recall information. DMS may be 
sensitive to damages mainly in the medial temporal lobe, but is also dependent on 
some inputs from the frontal lobe [12]. The most reliable result to report from this test 
was “total correct” answers, but we chose to report results on both “latency” and the 
number of correct responses on 0 and 12 seconds. Thereby we hoped to be able to 
distinguish between impairments in storing and recalling and also to differentiate 
between immediate and delayed memory.  
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3.3.4 Stockings of Cambridge (SOC) 
 
 
Picture 4: Stockings of Cambridge. 
The patient has to rearrange the three 
coloured balls displayed in the lower 
half of the screen to match the pattern 
in the upper half. The difficulty level 
increases as the minimum moves 
needed for rearranging the balls 
increases from two to five.
Stockings of Cambridge is regarded a test of executive function and requires spatial 
abilities and strategic planning. The abilities tested by SOC is claimed to give a 
measure of frontal lobe function [13]. As with DMS, is it possible to compare tasks 
with different difficulty level. We chose to report the number of “problems solved in 
minimum moves”, as this has been shown to be the most reliable result [14, 15]. In 
addition, we reported the “mean number of moves” and “subsequent thinking time” 
on 2 and 5 moves. Thinking time was only reported in the arachnoid cyst study.  
 
3.3.5 Paired associate learning (PAL)
 
 
Picture 5: Paired associate learning. 
One by one the white boxes “open” 
and reveals an empty space or a 
pattern. The patient has to remember 
the location of these patterns and then 
point out where on the screen the 
pattern initially was shown. The 
difficulty level increases as the number 
of boxes filled with patterns increases.  
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Paired associate learning is a test for episodic and visual memory but also depends on 
the ability of spatial planning. The performance in PAL depends mainly on inputs 
from the temporal lobe, but also from the frontal lobe [16]. We chose to report “total 
errors” and “total trials” needed to complete the tasks indicative of level of 
impairment. In addition “first trial memory score” was reported enabling us to report 
results from patients who did not complete the test because of high difficulty level in 
the last task. All reported results show high test-retest correlations.     
 
3.3.6 Big/little Circle (BLC) 
Picture 6: Big/little circle. The big and 
the little circle appear at changing 
locations on the screen. The patient is 
instructed to point on the little circle 
for the first 20 appearances and then 
on the big circle for the following 20.     
This test is a simple preparation test that is recommended to precede the intra/extra 
dimensional shift test to prepare the patient for this complex task. No results reported.  
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3.3.7 Intra-extra dimensional set shift (IED) 
 
Picture 7: Intra-extra dimensional set 
shift. Four boxes are shown on the 
screen. In two of the boxes there are 
one or two patterns. One of the 
patterns is the correct one to point at. 
The patients are supposed to disclose 
which one by a try-and-fail method. 
When the correct pattern is pointed at, 
the feedback “correct” is given. Then 
the patients should keep on pointing at 
the correct pattern until the rules are 
changed and another pattern is the 
correct one to point at. The rule 
changes after the patient has pointed at 
the correct pattern 9 times and by 
doing this verifies that the rule is 
disclosed. After the rule changes, the 
patient has to discover the new rule by 
finding the next correct pattern to point 
at repeatedly. Nine rules have to be 
disclosed to complete the whole test.     
 
IED is considered a test of executive function and depends primarily on fronto-striatal 
regions of the brain. IED tests visual discrimination and attentional set formation. It 
also tests maintenance, shifting and flexibility of attention [17]. “Number of tasks 
solved” was the most reliable result to report. In addition to this we reported “total 
errors” and “total trials” enabling us to differentiate between patients with poor 
achievements, i.e. those who solved few tasks. The BLC and IED tests were only 
used in the AC study to add an extra control test for frontal function. 
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3.4 Overview: additional diagnostic tools, registers and scoring systems  
3.4.1 Cerebral performance category (CPC)  
Cerebral performance category is a scoring system that is used to categorise the 
functional outcome after cerebral damage. It is frequently used to assess functional 
outcome, also in cardiac arrest survivors [20]. CPC confines both consciousness and 
other neurological disorders connected to the CA. Criteria for scoring are shown in 
table 2.  CPC 1 and 2 are considered good functional outcome.  
Table 2: CPC score and function level 
CPC score Function level 
1 Good cerebral performance 
2 Moderate cerebral performance 
3 Severe cerebral disability 
4 Coma or vegetative state 
5 Brain death 
 
3.4.2 Mini-mental state examination (MMSE) 
The Mini-mental state examination is an established and validated screening tool for 
cognitive impairments in general [21]. This test evaluates cognitive function through 
the evaluation of orientation, memory, counting, language and copying skills. The 
score range is 0-30 and patients with MMSE <24 are considered cognitively 
impaired. MMSE does not differentiate between cognitive domains and does not 
address more subtle cognitive changes. 
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3.4.3 Short Form 36 (SF-36) 
Short Form 36 is a general measure tool for assessing health related quality of life 
and measures eight dimensions: physical functioning, role physical, role emotional, 
social functioning, bodily pain, vitality, mental health and general health. The SF-36 
has been validated in a Norwegian population [22]. Results from SF-36 can be 
compared with age and sex matched reference populations allowing us to describe the 
tested patients’ HRQOL. SF-36 has been frequently used in research on survivors of 
critical illness and also in our department. It has previously been documented that 
HRQOL measured with SF-36 is significantly reduced after critical illness and also 
improves during the two first years after discharge from ICU [23, 24].  
 
3.4.4 Charlson co-morbidity index (CCI) 
Charlson Co-morbidity index (CCI) was used to document co-morbidity and to study 
the effect on possible brain dysfunction during ICU stay. CCI assesses diseases such 
as hypertension, COPD, diabetes, HIV, autoimmune disease, renal failure, and others 
to describe co-morbidity. CCI gives an age-adjusted score based on the patient’s pre-
existing medical conditions and can be used to estimate the risk of death based on co-
morbid disease in longitudinal studies [25].  
 
3.4.5 Sequential organ failure assessment (SOFA) 
The SOFA score system describes organ dysfunction and failure in the critically ill. It 
can be used to assess the effects of therapy on the course of organ dysfunction or 
failure. The SOFA scoring is based on objective assessment of function in six organ 
systems: Respiratory, coagulation, liver, cardiovascular, central nervous system and 
renal function. Dysfunction is classified from 0 (normal) to 4 (most abnormal) hence 
giving a score range from 0-24 [26]. In our department SOFA score is assessed every 
morning. We chose to report maximum SOFA score as an indication of severity of 
illness taken the whole ICU stay into consideration. 
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3.4.6 Simplified acute physiology score II (SAPS II) 
SAPS II collects information on 17 variables documented to affect hospital mortality 
in critically ill patients. Twelve of the variables are physiologic and describe organ 
affection during the 24 first hours after admission to the ICU. Further age, type of 
admission (scheduled surgical, unscheduled surgical or medical) and the presence of 
three possible underlying medical disorders (AIDS, metastatic malignancy, or 
haematological malignancy) are registered [27]. Based on these variables, hospital 
mortality is predicted. SAPS II can also be used as an expression of severity of illness 
at admission to the ICU.  
 
3.4.7 Registry of intensive care activity (REGINA)  
REGINA is a local registry collecting information about the individual patient 
regarding the stay in our ICU at HUH. In REGINA information such as age, sex, 
CCI, SOFA score, max SOFA score, SAPS II, SAPS III, length of stay, days on 
respiratory support and hospitality mortality is gathered. This was our main source of 
such information for each patient. If REGINA could not supply us with this 
information, journals or the electronic ICU chart (ICIP) were reviewed.  
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4. Summary of papers 
 
Paper 1: Reversible dyscognition in patients with a unilateral, middle fossa 
arachnoid cyst revealed by using a laptop based neuropsychological test battery 
(CANTAB) 
Arachnoid cysts (AC) are benign, congenital, space occupying malformations of the 
arachnoid. It is previously documented that ACs affect cognitive functions influenced 
by underlying areas of the brain and that this dysfunction can resolve after surgical 
decompression of the cyst. CANTAB has not been validated in Norwegian 
populations before. In this study we wanted to explore whether CANTAB could 
reveal the specific cognitive improvement after surgical decompression that one 
could expect according to cyst’s location, and thus to validate the test battery’s neuro-
anatomical specificity. We applied CANTAB in the parallel mode thus not enabling 
us to classify the preoperative level of cognitive function compared to the reference 
population. We prospectively tested patients with ACs in the temporal region with 
two memory tests that depend on inputs from a normal functioning temporal lobe and 
two executive tests more sensitive to frontal lobe function. Secondary we wanted to 
investigate HRQOL and possible changes in HRQOL after surgery in these patients. 
Twenty-two adult patients with unilateral temporal lobe AC were included and went 
through clinical examination, neuro-imaging, CANTAB, and they filled in SF-36 for 
evaluation of HRQOL. After a minimum of three months the patients where 
scheduled for a postoperative control. Fifteen patients were followed-up according to 
protocol including CANTAB. These 15 patients showed significant improvement on 
both memory tests, but no significant improvement on the executive tests. HRQOL 
was significantly reduced in two of eight domains in the group preoperatively. 
Postoperatively there were no such differences compared to the SF-36 reference 
population and scores had improved significantly in four of eight SF-36 domains.  
In patients with temporal lobe ACs we have documented improvement in cognitive 
functions depending on inputs from the temporal lobe, but no improvement in 
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functions more sensitive to an intact frontal lobe function. Hence we claim to have 
established construct validity for CANTAB and shown that CANTAB is applicable in 
a Norwegian cohort. 
 
Paper 2: Clinical validation of Cambridge Neuropsychological Test Automated 
Battery in a Norwegian epilepsy population 
Semi-automated neuropsychological testing has over the recent years gained a 
position both in clinical use and research. Still its role is debated and its use is 
hampered by the lack of validation studies and comparisons with more traditional and 
well-established neuropsychological tests. Validity of CANTAB is mainly 
established as construct validity, i.e. from investigating patients with known 
neurologic disease or brain lesion. The aim of this study was to compare the results 
from CANTAB with matched traditional, neuropsychological tests when testing 
epilepsy patients and by doing this establish cross-tests validity for CANTAB in a 
Norwegian population. As a general hypothesis we expected that measures from 
short-time (DMS) and visual memory (PAL) tests from CANTAB would show high 
correlations with measures of non-verbal memory from WMS-R and that measures 
from CANTAB’s executive test (SOC) would show higher correlations with 
intelligence and measures from the HRB thought to measure executive functions. We 
prospectively included 15 patients ≥ 16 years who where scheduled for clinically 
indicated neuropsychological assessment with a neuropsychologist. The patients were 
asked to also complete CANTAB testing during their stay in the ward. All patients 
were classified with or without cognitive impairment based on results from both 
CANTAB and results from traditional testing.  
Twelve of 15 patients were classified identically based on the two different test 
methods. Furthermore, one measure from DMS correlated uniquely and strongly with 
results from Visual paired associations 1 from WMS-R. Measures from SOC 
correlated both with tests for visual Memory, General Memory, Full Scale IQ and 
Performance IQ. Results from PAL revealed the most complex correlations: Verbal, 
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Visual and General Memory indexes and in addition Paired Associations and Visual 
Memory Span (backwards), Trail Making Test B and Visual IQ. This indicates that 
DMS is a unique test for visual matching to sample and hence depending mainly 
upon the temporal lobe. SOC depends both on memory and reasoning and PAL is a 
complex task demanding both the use of different memory skills and intelligence. 
Even though SOC is regarded an executive test, we found that several memory 
aspects also correlate with this test. Still Performance IQ shows the strongest 
correlation. Thus, SOC is not completely independent of temporal lobe function, but 
the test is mainly dependent on an intact frontal lobe. The strong correlations between 
several memory tests and PAL may reflect the dependency on temporal lobe function. 
We consider this a criterion validation of CANTAB in a Norwegian epilepsy 
population.  
 
Paper 3: Cognitive dysfunction and health-related quality of life after cardiac 
arrest and therapeutic hypothermia 
Improved hospital survival to over 50% after OHCA with modern treatment 
protocols, including therapeutic hypothermia, has lead to increased focus on 
functional outcome in these patients. 75-100% of the survivors after OHCA survive 
with a good functional outcome, i.e. CPC 1-2. In this study we wanted to investigate 
cognitive functions and health-related quality of life in OHCA survivors with CPC 1 
or 2 one year or more after hospital discharge. We retrospectively included 26 OHCA 
survivors (23 males and 3 females) from two Norwegian centers who offered modern 
post-cardiac arrest treatment including TH. Median age was 61.5 years (range 22-79).  
All patients were screened with MMSE and 24 patients were subsequently tested with 
CANTAB. Twenty-five patients filled in SF-36 for evaluation of HRQOL.  
A total of 13/25 (52%, CI: 31-73%) patients were classified as having cognitive 
impairments. One patient scored < 24 on MMSE and 12/25 patients had cognitive 
impairments according to CANTAB testing. In this study the OHCA group scored 
significantly lower than the CANTAB reference population on cognitive tests 
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assessing executive function and spatial memory. There was no significant difference 
in HRQOL between the OHCA group and the SF-36 reference population. We found 
no significant relationships between age, HRQOL, time since OCHA and cognitive 
function. Our results indicate that cognitive dysfunction is common in OHCA 
survivors even though they report normal HRQOL. The most commonly reported 
cognitive dysfunction after CA in general is memory disturbances and executive 
dysfunction. Especially deficits in short-time memory are often reported after CA. 
Our patients did not score worse than the integrated reference population on the test 
of short-time memory, but significantly worse regarding spatial memory. We were 
able to reproduce executive dysfunction reported by other authors. Twelve of the 
patients with MMSE ≥ 24 were classified as having a cognitive dysfunction. This 
indicates that CANTAB can reveal more subtle changes in cognitive function than 
MMSE.  CANTAB proved able to discover cognitive dysfunctions in OHCA 
survivors and it was possible to use it in a CA survivor cohort.  
 
Paper 4: Cognitive impairments after critical illness – incidence and 
consequences 
This study focused on the effect of critical illness on cognitive function. The main 
aim was to estimate the incidence of cognitive impairments in patients discharged 
from our ICU immediately after discharge and after three and twelve months. 
Secondarily we looked for predictors of adverse cognitive outcome and wanted to 
analyse how being cognitively impaired would correlate with mortality, morbidity 
and health related quality of life. To isolate the effect of being critically ill on 
cognitive function, we excluded all patients with known pre-ICU cognitive 
impairments or who had an increased risk of having cognitive impairments before 
admittance. In addition all patients with present brain injury, brain disease or known 
cerebral complications were excluded. We also recruited a surgical comparison group 
consisting of patients who had gone through major surgery, to compare level of 
cognitive performance with the ICU patients. During a period of 14 months we 
prospectively included 55 ICU patients. After discharge from ICU, 18 of 28 (64%) 
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patients had a cognitive impairment according to Jackson’s criteria. Twenty-seven 
patients were not possible to classify because they did not complete CANTAB.  The 
incidences of cognitive impairments at 3 and 12 months were 11% (95% CI: 0-23%) 
and 10% (95% CI:-1-21%), respectively. The ICU patients scored worse on eight out 
of ten measures, but only significantly on one, compared with the surgical control 
group. In the ICU patients, level of cognitive performance was reduced in all tested 
cognitive domains (short-term memory, executive function and visual memory) at 
discharge compared to a normal reference population. At three months only scores on 
memory tests were reduced; at twelve months the ICU group scored significantly 
worse on only one of twelve measures. We found no associations between ICU 
related cognitive impairment and mortality, morbidity, HRQOL or any aetiological 
factors. Our results indicate that cognitive impairments are common after discharge 
from ICU even in patients with no known pre- or in-ICU elevated risk of such 
impairment. This may indicate an effect of critical illness per se on cognition.  
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5. Discussion 
5.1 Summary of main findings 
CANTAB tests have been demonstrated to have construct validity in Norwegian 
arachnoidal cyst (AC) patients 
CANTAB tests and CANTAB’s reference population have been cross-test validated 
in a Norwegian epilepsy population 
Our established CANTAB test battery and applied criteria reproduced incidences and 
described cognitive impairments in ICU patients comparable to previous studies  
CANTAB proved feasible in neuropsychological testing of survivors of critical 
illness 
Cognitive impairments are common after cardiac arrest treated with therapeutic 
hypothermia, but are not associated with health related quality of life 
Cognitive impairments is common after critical illness in general  
After discharge, the incidence of cognitive impairments in patients with no known 
pre-ICU or in-ICU risk of such impairments is quite high (64%), but drops rapidly at 
three and twelve months to 11% and 10 %, respectively  
Being critically ill may in itself cause cognitive impairment  
We found no associations between pre- and in-ICU factors and the development of 
cognitive impairments 
Cognitive impairments were not associated with mortality, morbidity or HRQOL 
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5.2 Cognitive dysfunction after critical illness 
5.2.1 Brain dysfunction in general – terminology and classification 
Damage to, or affection of, the critically ill patient’s brain can have both primary and 
secondary causes. The affection may be focal or global and span throughout the 
whole register of severity: brain death, permanent vegetative state, locked-in 
syndrome, hemi-paresis, aphasia, delirium or cognitive impairments. The conditions 
may be chronic and irreversible or acute and fully reversible. Brain damage can arise 
secondary to primary insult to the brain or primary disease in other vital organs. In an 
updated article by Stevens and Nyquist [28], the authors focus on classification of 
brain dysfunction, aetiology and possible outcomes. They emphasise the importance 
of rationalising and systematising the terminology and the diagnostic approach. Their 
main objective is the global alteration in cognitive function seen in many critically ill 
patients. Stevens and Nyquist recommend that the spectrum of such brain dysfunction 
seen during or after critical illness is described as coma, delirium or cognitive 
impairments. This facilitates a systemised approach both regarding diagnosis, 
treatment and prognostic evaluations. Below, I will discuss further the classification 
of Stevens and Nyquist. 
Coma 
Coma is characterised by a severe disruption in wakefulness or awareness [28]. 
Stevens and Nyquist agree with Aristotle that awareness is the content of 
consciousness and depends on several cognitive skills such as perception, attention, 
memory and executive function. The clinician can make use of the Glasgow Coma 
Scale (GCS) when approaching the unconscious patient [29]. GCS is validated in 
several patient populations and are widely used for expressing patients’ level of 
consciousness. GCS below 8 is regarded being in a comatose condition.  
Delirium 
In delirious patients, consciousness is altered, but some degree of wakefulness and 
awareness is kept. Delirium is further characterised by a general cognitive 
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impairment, confusion, altered attention, fluctuating course and disorganised thinking 
[30]. Delirium can be expressed both as a hyperactive delirium in an aggressive 
patient or as a hypoactive delirium where the patient is in a state of apathy. Confusion 
assessment method for the intensive care unit (CAM-ICU) is a validated tool for 
diagnosing ICU related delirium [31].   
Cognitive impairment 
Patients with isolated cognitive impairment during or after critical illness are fully 
alert and conscious. Their impairment is often not suspected by the ICU team unless 
in very grave cases where patients show signs of disorientation or confusion. The 
main aspect distinguishing delirium and cognitive impairment is consciousness, 
which fluctuates in delirium but is intact in cognitively impaired patients. Isolated 
cognitive impairments are more likely to be discovered days, weeks or even months 
after discharge from the ICU. If a cognitive impairment is suspected or if the clinician 
wants to screen for such impairment, MMSE [21] is the most used validated tool. 
MMSE is however a gross measure of cognitive function and may not reveal more 
subtle changes; nor can it describe the affected cognitive domain precisely.  
Several and different specific conditions or diseases that may cause ICU related brain 
dysfunctions have been described, such as septic encephalopathy, ICU psychosis, 
acute organic reaction and cerebral insufficiency. These terms link aetiology and 
clinical presentation, which may limit their use. The terms recommended by Stevens 
and Nyquist focus on clinical presentation solely.  
To make the delirium diagnosis some observational time is demanded to determine 
fluctuation in consciousness, but otherwise GCS, CAM-ICU and MMSE can rapidly 
give the diagnosis bedside in most cases. It is important to emphasise that other 
diagnoses involving brain dysfunction, such as dementia, including Alzheimer’s 
disease, cannot be diagnosed in an ICU setting. The dementia diagnosis demands 
long follow-up time and also depends on activity of daily life, which is not possible to 
assess during the acute, critical phase. On the other hand pre-clinical variants of the 
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conditions mentioned above may be revealed during critical illness, thus making them 
relevant during follow up and rehabilitation.   
 
5.2.2 Aetiology and epidemiology of cognitive impairments – predisposing and 
precipitating factors 
As with other organ dysfunctions developed during critical illness the aetiology of 
brain dysfunction in general, and cognitive impairment in particular, is believed to be 
multifactorial. It is common to sort risk factors or possible causes for developing 
brain dysfunction such as delirium and cognitive impairment into pre-ICU 
(predisposing) factors and in-ICU (precipitating) factors indicating the importance of 
the patient’s health condition before admittance to the ICU [32, 33]. Generally, there 
is more evidence of the impact of pre-ICU factors on brain function than of in-ICU 
factors, especially between severe brain dysfunction, such as delirium, and pre-ICU 
factors. There is strong evidence for an increased risk of delirium in patients with pre-
existing dementia, advanced age, use of psychopharmacological drugs, sepsis, 
mechanical ventilation, heart-failure, and other conditions [34]. These associations 
are less strong for cognitive impairment, but it is nevertheless believed that delirium 
and cognitive impairments share several aetiological and risk factors. This is 
underlined by the fact that delirium during ICU stay increases the risk of sustained 
cognitive impairment also after ICU discharge [28]. 
Pre-ICU factors 
Previous studies have established the association between pre-ICU factors and 
adverse cognitive outcome: gender (male>female), low functional status, lower 
educational achievement, malnutrition, cardio-vascular disease, previous brain 
injury/disease, medical disorders, drug/alcohol abuse and pre-existing cognitive 
impairment [32]. When controlled for other factors, age has not previously been 
isolated as a predisposing factor for cognitive impairment alone, cognitive 
impairment strikes ICU patients in all ages. The risk of having other predisposing 
conditions increases with age and this might explain the fact that cognitive 
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impairments are more common in elderly than in younger ICU patients. Some 
patients have subclinical conditions of dementia or other brain disorders prior to 
admittance to the ICU. Such conditions may also predispose for the development of 
cognitive impairments or the underlying condition may fully reveal during or after 
critical illness.    
We found no association between any etiologic factor and the development of 
cognitive impairments. As claimed by other authors [28] it will probably demand 
larger multi-centre studies to reveal predictors for cognitive impairments in general, 
not only the severe forms. It is therefore possible that we miss such associations 
because of the relatively low number of patients tested.  
In-ICU factors     
Regarding in-ICU factors several aetiological contributors are suspected: CNS 
disease, hypoxemia, hypo-perfusion, infection/sepsis, sedatives/neuroactive 
pharmacological agents, metabolic derangement, systemic inflammation, glucose 
dysregulation, mechanical ventilation and several others [7, 28, 32, 33, 35]. Studies 
on ARDS patients have revealed that degree of hypoxemia correlates significantly 
with cognitive impairment [7]. Whether this applies for critical ill patients without 
ARDS is suspected, but not documented. The human hippocampus is regarded as 
being especially sensitive to hypoxia and it is known that hypoxia in the temporal 
lobe may cause memory deficits [36]. Thus hypoxemia, with suspected resulting 
cerebral hypoxia, is the most documented in-ICU etiologic factor for cognitive 
impairment.  
It has not been demonstrated that factors describing the severity or magnitude of the 
disease will influence the risk of developing cognitive impairment. The factors that 
were explored include length of stay in ICU, duration of mechanical ventilation, 
APACHE II scores, days of receiving sedatives and tidal volume [32].  
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Effect of being critical ill on cognition 
It is important to distinguish between structural brain damage caused by localised 
primary or secondary brain injury and diseases that may result in diffuse or scattered 
brain cell death and brain dysfunction. Even though structural brain damage and brain 
cell death will contribute to the incidence of brain dysfunction, it is possible that 
being critically ill in itself may have an effect on brain function. As seen above, 
several suspected in-ICU aetiological factors are not directly associated with brain 
dysfunction. Infection, sepsis, mechanical ventilation, metabolic derangement, 
immunological activity and other factors may possibly affect brain function with 
clinical manifestations, but without leaving trace of structural brain damage that are 
visible on routine CT or MRI scans. Meanwhile neuropathological evidence is 
emerging showing how both critical illness and its treatment can cause de novo 
cerebral atrophy. Gunther et al. describes how disrupted function in the ascending 
reticular activating system (ARAS) caused by sepsis, ARDS, ALI or its treatment can 
alter consciousness and thus contribute to the explanation of ICU delirium [37].  
By excluding patients with known brain injury/disease, known brain dysfunction, or 
increased risk of developing such dysfunction, it is possible to explore the effects on 
cognition of being critically ill.  We found significant differences between the ICU 
patients and a normal population as well as a surgical reference group. There was 
only significant difference between the ICU group and the surgical group on one 
result from CANTAB testing, but a trend towards poorer scores in the ICU group 
(table 3).The surgical control group had significantly higher co-morbidity and age 
than the ICU group. Exclusion criteria were the same in the two groups. Increasing 
age and co-morbidity predicted reduced level of cognitive function in ICU patients.  
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Table 3: Level of cognitive performance in ICU and surgical patients with MMSE 
≥24, as revealed by 4 different CANTAB tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p(I/S): Comparison of level of cognitive performance between the surgical end the ICU group. Paired-sample 
t-test. 
 
Incidences of cognitive dysfunctions in ICU patients 
The incidences of brain dysfunctions in general and delirium and cognitive 
impairments especially vary greatly between different subgroups of critically ill 
patients. In general ICU cohorts it is reported that up 80% of patients are delirious at 
some time during their ICU stay [34]. Cognitive impairments are reported to range 
between 25% and 80% in different ICU cohorts. Selected studies documenting these 
incidences are summarised in table 4 [7, 38-43].   
 
 ICU group at ICU 
discharge 
Surgical group, 1-7 
days postoperatively 
 
CANTAB test/measure n Mean (SD) n Mean (SD) p(I/S) 
MOT      
Mean Latency 50 -0.93 (1.33) 23 -0.72 (0.84) 0.481 
DMS      
Mean correct latency 50 -1.25 (1.98) 21 -0.32 (1.06) 0.045* 
Total correct 50 -0.82 (1.63) 21 -0.21 (1.10) 0.124 
Percent correct, 0 sec 50 -0.33 (1.41) 21 0.06 (1.01) 0.252 
Percent correct, 12 sec 50 -0.65 (1.30) 21 -0.16 (1.01) 0.123 
SOC      
Problems solved in minimum moves 33 -0.48 (1.11) 18 -0.29 (1.00) 0.544 
Mean moves, 5 moves 33 0.40 (0.89) 18 0.77 (1.10) 0.198 
Mean subsequent thinking time, 5 moves 33 -0.93 (2.44) 18 -1.19 (2.36) 0.072 
PAL      
Total errors adjusted 17 -2.10 (3.89) 17 -1.63 (3.05) 0.699 
1st trail memory score 19 -1.18 (1.86) 17 -0.74 (1.55) 0.451 
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Table 4: Incidences of cognitive impairments in different patient cohorts evaluated at 
different points of time 
 
From these previous reports it is reasonable to assume that cognitive impairment is 
common after critical illness. The trend in these results is that cohorts with patients 
who suffered from ARDS or were in need of respiratory support both showed high 
incidence of cognitive dysfunction during their stay in ICU and had the highest 
prevalence of chronic cognitive impairment. Patients examined after cardiac arrest 
had also high prevalence of such impairment more than one year after the incident. 
This indicates that patients with hypoxemia [7, 41], increased risk of hypoxemia [40], 
or increased risk of cerebral hypo-perfusion [38, 43] are at greater risk of developing 
cognitive impairment, thus underlining the aetiological role of hypoxia. The two 
studies including medical and surgical ICU patients in general [39, 42] had the lowest 
incidences of cognitive impairment. Based on results from these studies it is possible 
to argue that patients with hypoxemic aetiology are more likely to develop chronic 
cognitive impairment. 
Our results emphasise these perspectives. The incidence of cognitive impairments in 
the ICU group was high immediately after discharge (64 %) but dropped rapidly to 11 
Author Patients During 
ICU 
Before/at hospital 
discharge 
2-6 months 
after ICU 
> one year 
after ICU 
Hopkins et al, 1999 
[7]  
ARDS  100%  78% 
Hopkins et al, 2005 
[44] 
ARDS  70%  45-47% 
Sukantarat et al, 
2005 [42] 
General ICU    35%  
Jones et al, 2006 
[40] 
Mechanical ventilated, 
non delirious patients. 
100% 50% 50%  
Cronberg et al, 2009 
[38] 
Cardiac arrest    50% 
Rothenhausler et al 
2001 [41] 
ARDS    23.9%       
(6 years) 
Jackson et al 2003 
[39] 
Medical ICU   32%  
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% after three months indicating that cognitive impairments disappear in most general 
ICU patients after ICU discharge. In our CA group, where inclusion and exclusion 
criteria were the same and which was tested with the same CANTAB battery, 
incidence of cognitive impairment was 52 %. Age difference between the CA and 
ICU group was significant (61.5 vs 51.3 years respectively, p-value: 0.018). Anyhow, 
age alone cannot account for the major difference in incidence of cognitive 
impairments at 1-2 years after CA or ICU discharge. The other major difference 
between these groups was the confirmed episode of cerebral hypo-perfusion with 
possible resulting cerebral hypoxia in the CA patients while such an incident is less 
likely for the ICU patients. We believe this supports the aetiological role of hypoxia. 
Cognitive deficits that are present one year after the incident are regarded permanent 
[45]. Some authors claim that deficits become permanent even earlier [46]. The 
difference in incidences from these two cohorts indicates that patients who have 
suffered from cerebral hypoxia are more likely to develop permanent cognitive 
impairment. 
When former ICU patients have such a high incidence of cognitive impairments at 
discharge that subsequently drops significantly already after three months, this 
observation may indicate that cognitive impairment in general ICU cohorts is not 
caused by cerebral hypoxia alone and that there are other aetiological factors, as 
suspected by other authors [32].  
 
5.2.3 Cognitive impairments and outcome 
Mortality and morbidity 
In the study on former ICU patients we investigated mortality and one morbidity 
factor; institutionalisation. We found no differences in these adverse outcomes 
between patients with or without cognitive impairments. Are cognitive impairments 
then without consequences? POCD is not an identical condition to cognitive 
impairments after critical illness, but the two conditions are comparable. In addition 
to institutionalisation several POCD studies also have evaluated postoperative length 
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of stay, costs, hospital length of stay and medical complications. Most research on 
POCD includes also non-delirious patients with MMSE < 24. Perhaps some of the 
differences regarding mortality and morbidity between POCD and our studies can be 
explained by the fact that the POCD group contains more cognitively impaired 
patients, but it is also possible that this is caused by study strength since referred 
POCD studies assessed more patients than we did. Studies on cognitive impairment 
after CA have also concluded with negative effects of cognitive impairment on 
morbidity. Again these studies include more cognitively impaired patients and also 
more patients, but they also assess more numerous adverse outcomes such as 
employment status, dependency on social benefits and functional level [38].   
Patients with MMSE ≥ 24 are described as having a normal general cognitive 
function. The cognitive impairments documented in our study include subtle changes 
that probably are most relevant regarding complex tasks. Hence it is possible that 
these changes affect groups of patients in different ways. Most CA patients and ICU 
patients are in the upper age groups and therefore retired or unemployed after CA or 
ICU stay. Perhaps these patients to a lesser degree are exposed to tasks in daily life 
which are affected by subtle cognitive changes. This underlines the importance of 
including information of pre- and post-critical illness level of education, functional 
status, and employment status when assessing such possible adverse effects of 
cognitive impairment in different patient groups.  
HRQOL 
Even though we documented a cognitive impairment in more than 50% of the CA 
patients’ HRQOL was normal in the CA group compared with a Norwegian reference 
population. This is in accordance with previous studies on HRQOL in CA cohorts 
where it is documented that most of the improvement occurs during the first year 
after the CA [46] and that CA patients is quite similar to the normal population after 
one year [46-48]. There was no correlation between HRQOL measured with SF-36 
and measured level of cognitive performance in our findings. Even though former 
ICU patients show reduced quality of life compared with the normal population both 
at 3 months and 12 months follow-up, there was no correlation to the level of 
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cognitive performance in this group either. We could not document any effect on 
HRQOL of having cognitive impairments after having been critically ill.  
 
5.2.4 Types of cognitive functions that may be affected after critical illness 
Previous investigations of cognitive function in these patient groups have been 
performed with a large variety of different cognitive tests and test batteries. The 
cognitive approach also differs in timing of testing, the follow-up intervals and the 
complexity of test batteries. When reviewing the relevant literature, it is difficult to 
discover an obvious or simple recipe for the cognitive approach, however some 
common features are revealed. 
Research on hypoxic brain injury has often focused on memory deficits and on 
hippocampal damage. Thus, it is well documented that memory deficits and temporal 
lobe affection may follow from hypoxic or anoxic brain injury [49-51]. Executive 
functions have also been evaluated in several cohorts of patients with hypoxic brain 
injury, but not to the same extent as memory. Even so, executive dysfunction and 
behavioural changes have been revealed as a common cognitive deficit after cerebral 
hypoxia, often in combination with memory deficits [49, 51]. Executive dysfunction 
is often linked to frontal lobe affection, and it is claimed that hypoxic injury can 
cause “frontal lobe syndromes” explaining behavioural changes [52]. Several authors 
also emphasise the deterioration in visuospatial skills, which indicates possible 
parietal affection after hypoxic events [36, 49, 52]. When memory deficits are further 
explored both verbal and visual memory impairments are discovered [51]. Immediate 
memory and recognition memory seem to be lesser affected than delayed memory 
[49, 51-53]. 
The dominance of memory disturbances among reported cognitive impairments after 
critical illness is most likely due to the fact that this is the most investigated cognitive 
domain, not necessarily the most affected domain [54]. 
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Research focusing not only on hypoxia, but on other aetiological factors such as 
critical illness and CA shows similar patterns. A hypoxic mechanism is believed to be 
the cause of the well-documented cognitive impairments arising after the CA. Even 
though investigated in different ways and with different methods, memory 
impairments, various executive deficits and also motor/speed deficits are often 
reported after CA [47, 55-57]. Also in CA patients, memory impairments seem to be 
the most robust finding [38, 48, 58]. Delayed recall was one of the most frequently 
reported sub-categories of memory impairment [48].  
Regarding critically ill patients in general several types of cognitive impairments and 
affection of several domains have previously been reported [54, 59]. Memory and 
executive functions are the most investigated cognitive domains, even though several 
other deficits such as attention, planning, mental processing speed, language and 
visuospatial abilities also have been investigated and reported to be affected [7, 32, 
40, 42, 48].  
In our two studies on critical illness survivors we assessed motor speed, delayed 
memory, immediate memory, forced decision-making, visual memory, spatial 
memory and executive functions. As documented, both SOC and PAL are complex 
tests where achievements depend on several sub-functions. Considering the ICU and 
CA studies together, we found reduced cognitive level of performance in all domains 
except for immediate memory (DMS, 0 seconds delay). Immediate memory is earlier 
documented to be less affected than delayed memory in post-ICU or anoxic cohorts. 
Our finding agrees with this statement. Our results also confirm the complexity in 
cognitive impairments arising after critical illness. It is quite possible that more tests 
on other cognitive domains would have revealed even larger diversity in cognitive 
impairments.  
5.2.5 Confounding factors regarding cognitive impairments caused by critical 
illness  
We aimed to exclude patients with pre-ICU increased risk of cognitive impairments. 
Patients with severe psychiatric disorders were not included due to increased risk of 
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cognitive impairments. On the other hand we have not assessed the ICU group or CA 
group for psychiatric disorders that may have emerged after critical illness. It is 
previously documented that both CA and ICU survivors have higher prevalence of 
depression and anxiety believed to be caused or triggered by having had a critical 
illness [38, 60]. In addition, these patients are at risk of developing post-traumatic 
stress disorders (PTSD) [61, 62]. All these conditions (anxiety, depression and PTSD) 
can be accompanied by a reduced level of cognitive function. We did not search for 
these conditions in our cohorts; it is therefore possible that they partly can explain 
some of the documented reduced level of cognitive performance. Even so, these are 
also consequences of being critically ill. As with other possible etiological factors 
(sedation, inflammation, sepsis) we did not look for the individual factor itself, just 
the aggregated effect of critical illness on cognition.  
Many patients will be in continuous need of analgetics and sedatives after discharge 
from the ICU. The use of opioids, alpha-2 agonists or benzodiazepines after ICU can 
affect performance on cognitive tests [63, 64]. In addition, the possibility exists that 
patients with renal or hepatic failure still are under the influence of both opioids and 
benzodiazepines, or their active metabolites, long after the ICU stay.  
 
5.3 Validity of CANTAB 
5.3.1 General perspectives on test validity 
There is no unambiguous definition of validity. Validity usually refers to to what 
extent a measurement generated from a study or a test represents the real world. The 
meaning of validity also varies depending on the context. In experimental studies, 
validity is often described in to ways: 1. External validity, which expresses whether 
the results can be transferred or generalised. 2. Internal validity addresses study 
design, how measures were conducted, accuracy in data collection, what was/was not 
measured, or if there are other possible explanations for any causal relationships 
found. Hence when applied here, validity concerns aspects of the study in itself.  
 54 
In this thesis another use of the term “validity“ is more relevant. In psychometrics 
(psychological testing) validity refers to the test validity, i.e. to which extent the 
applied test actually measures and further describes the feature under investigation. 
Traditionally, several types of test validity have been described; among them 
construct validity and criterion validity, concepts that are discussed below. 
Construct validity seeks agreement between a theoretical concept, or a construct, and 
a specific measuring device or procedure. Based on theory and empirical data, a 
construct is established. This construct then represents the theoretical explanations of 
how and why this procedure should measure the functions approached and which 
results one could expect. If the postulated results are documented or the results are in 
accordance with theory, construct validity is established. Both confirming the tests 
ability to correct measure the wanted feature (convergent validity) and the tests 
failure to detect other features (discriminant validity) are of interest when validating 
psychometric tests.  
With criterion validation a criterion is defined as a representative of the construct. 
This criterion can be described as a “gold standard”. To validate the test results, the 
test under investigation can be compared with the results from the representative test, 
i.e. the criterion. If the criterion test and the investigated test are carried out 
simultaneously and the results correspond, concurrent validity is established. 
Pearsons correlation coefficient is one statistical analysis that may be used to look for 
agreement between the investigated test and the criterion. 
This categorisation of test validity into different separate types of validity has over 
the recent years been challenged by another approach to validity. The concepts of 
construct validity and criterion validity are still relevant, but are now viewed more as 
two of several contributors to the validity of a test. A test is not regarded thoroughly 
validated unless several of the features of validity are documented; it is not sufficient 
to establish only one aspect of validity.  
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5.3.2 Previous validation of CANTAB 
Several validation studies have been performed with CANTAB. Cross-test 
validation/concurrent validation has been performed with some of the CANTAB tests 
and traditional neuropsychological tests such as Wisconsin card sorting test, 
Wechsler memory scale-revised and Digit span forward [65-67]. Generally, 
correlation coefficients are acceptable, but not all CANTAB test are validated in this 
way and the role of automatic test batteries such as CANTAB are debated because 
such validation studies are sparse [67]. Several studies have focused on construct 
validity of CANTAB. CANTAB is used to examine patients with different CNS 
profiles. CANTAB has proved able to detect neuropsychological deficits that were to 
be expected from the patients’ CNS disease or damage. Studies on patients with 
excisions of the temporal or frontal lobes, or who have been subject to amygdalo-
hippocampectomy, have given researchers information on how these structural 
changes may affect performance on several CANTAB tests [12, 16, 17]. In addition, 
CANTAB has been used to evaluate patients with neurological and neurosurgical 
disorders such as Huntington’s disease [68], Parkinson’s disease [69], Alzheimer’s 
disease [70], stroke [5], head injuries [6] and normal pressure hydrocephalus [71].  
Factorial validity concerns the scales of measurements used to describe function. By 
applying the test on a large, presumably healthy, normal population baseline data is 
gathered allowing for direct comparison between reference population and groups 
under investigation. These baseline data has been obtained through large factor 
analytic studies on children, adults and the elderly [72-74] in addition to be applied 
on more than 2000 normal controls to establish the integrated normative database 
[75].  
The main challenge in our research is that CANTAB has not been documented in the 
Norwegian population and that its use in critically ill patients is limited. In addition, 
several of our tests have not been cross-test validated with traditional 
neuropsychological tests and the test battery is weakened by the fact that the 
reference population is English. We needed to address these issues.    
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5.3.3 Test-retest correlations - reliability 
Test-retest correlations concern how much agreement there is between results from 
testing the same person with the same test at two different times. Low test-retest 
correlations indicate that factors other than those that we want to explore also affect 
the results. High test-retest correlation indicates high reliability of the test.  
Composing reliable tests batteries and choosing robust and relevant results to report is 
a challenge. These considerations are especially relevant when designing batteries 
and studies meant to measure changes over time or after therapeutic interventions. A 
study by Lowe and Rabbitt addresses test-retest reliability in CANTAB [15]. Tests 
addressing executive or frontal functions are regarded as not being very reliable 
because discovering and remembering strategies can improve the performance. Tests 
measuring metric values such as speed or accuracy are on the other hand regarded as 
being more reliable and often show high test-retest correlation. In this study the 
patients were tested and retested with an interval of four weeks.  
From each CANTAB test a wide selection of results is possible to report. Not all 
results are relevant and some results have higher test-retest reliability. After adequate 
tests are chosen, the researcher can further improve robustness of the results by 
choosing to report result with high test-retest correlations. Test-retest correlations 
relevant to our battery are shown in table 2.  
 
5.3.4 Composing the CANTAB battery for ICU patients 
When composing a neuropsychological test battery, several considerations must be 
addressed: which cognitive domains are of interest given the questions raised, are 
there valid tests, and which test results are most reliable? 
CANTAB has previously been used in only one study on critically ill patients. Jones 
et al. investigated non-delirious patients during and after ICU stay with two tests from 
CANTAB: DMS and SOC [40]. Cognitive impairment were documented on both 
tests both during and after ICU stay.    
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Based on earlier investigations on cognitive impairments after critical illness (see 
section 4.3.4), it was evident that our test battery had to include memory and 
executive tests. Tests for verbal memory in CANTAB are not translated to 
Norwegian so we had to focus on visual memory and included tests that also tested 
delayed memory. We included two memory tests and one executive test. This reflects 
both the need to focus on memory deficits and test-retest considerations.  
The tests included and the reported results with test-retest correlation with study 
populations are listed in table 6.   
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Table 6: Test-retest correlation published by Lowe and Rabbitt [15] and by Camcog 
in the CANTAB reliability study [14] on the tests we used  in our studies. Overview of 
reported results in the four studies where we have used CANTAB 
* indicates which result were reported in the different studies 
CANTAB test/reported result Test-retest 
correlation 
coefficient, 
Lowe and 
Rabbitt [15] 
Test-retest 
correlation 
coefficient, 
Camcog [14] 
Reported in 
archanoid cyst 
study  
Reported in 
CA, ICU and 
epilepsy study 
Motor screening test (MOT)     
Mean latency    * 
Delayed matching to sample (DMS)     
Total correct, all delays  0.56 0.50 * * 
Mean latency, all delays    * * 
Total correct, 0 seconds    * * 
Total correct, 12 seconds  0.34  * * 
Mean latency, 0 seconds    *  
Mean latency, 12 seconds    *  
Stockings of Cambridge (SOC)     
Problems solved in minimum moves, all  0.60  * * 
Mean moves, 2 moves    * * 
Mean moves, 5 moves  0.47  * * 
Mean subsequent thinking time, 2 moves   *  
Mean subsequent thinking time, 5 moves    *  
Paired associate learning (PAL)     
Total errors, adjusted   0.68 * * 
Total trails, adjusted 0.86   CA/epilepsy 
1st trail memory score  0.68  * ICU/epilepsy 
Intra-extra dimensional shift (IED)     
Stages completed   0.75 *  
Total errors, adjusted   0.40 *  
Total trials, adjusted    *  
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5.3.5 Validation in Norwegian patients 
ACs are most commonly located in the temporal lobe region [76]. Previous studies on 
cognition have shown that ACs may compromise neighbouring brain tissue, probably 
by affecting cerebral perfusion [77, 78] and further that cognitive dysfunction is 
reversible after surgical decompression of the cyst [79-83]. We applied a battery of 
two memory tests mainly assessing temporal lobe function (DMS and PAL) and two 
executive tests mainly assessing frontal lobe function (SOC and IED) pre- and 
postoperatively to patients operated for temporal ACs. We documented significant 
improvement in the two tests that mainly assessed temporal lobe function (DMS and 
PAL); no improvement was seen on the tests with lesser inputs from the temporal 
lobe (SOC and IED) [84]. Our findings are in accordance with other studies focusing 
on temporal and frontal lobe function [17, 74] and we believe that these results for the 
first time confirm construct validity (convergent and discriminant, respectively) of 
CANTAB in a Norwegian population. 
Patients with epilepsy have proven to be at risk of developing cognitive dysfunctions. 
Such cognitive dysfunctions were explored in Norwegian epilepsy patients and 
traditional neuropsychological tests and test batteries were validated in this patient 
group [85, 86]. During a clinically indicated follow-up at the Department of 
neurology, HUH, epilepsy patients were tested with Wechsler memory scale-revised, 
Wechsler adult intelligence III, Category test, and Trailmaking B test. We applied 
CANTAB in the clinical mode to these epilepsy patients in order to compare these 
Norwegian epilepsy patients with the integrated English reference population.  
The CANTAB and the traditional test battery showed high degree of agreement in the 
classification of cognitive impairments. Twelve of 15 patients were similarly 
classified as being impaired or not impaired in the 2 test batteries. Only three patients 
with focal cryptogenic epilepsy, generally regarded more benign than other forms of 
epilepsy, were classified differently by the two batteries. This might be due to lesser 
impact on cognition by this form of epilepsy. In addition to agreement between the 
two methods of classification, several significant correlations were found between 
CANTAB tests and traditional test assumed to probe similar functions (Pearson 
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correlation coefficient). This observation adds strength to our assumption that 
CANTAB can be used to evaluate Norwegian hospitalised patients. 
 
5.3.6 Summary of validation studies and recommendations for the use of CANTAB  
Do the results from these to validation studies correspond with each other? The AC 
study establishes DMS and PAL as tests that depend on intact temporal lobe function. 
This is confirmed by the epilepsy study, but these tests also seem to a certain degree 
to be dependent on frontal function. Our results thus seem to be corresponding with 
emerging knowledge of cognitive functions: these functions are multi-dimensional 
and difficult to describe using few factors. The epilepsy study shows that both DMS 
and PAL are memory tests, but also that DMS tests visual memory while PAL is 
more complex and investigates memory in general.  
The only executive test evaluated in both studies is SOC. By not being sensitive to 
decompression of ACs in the middle fossa, we concluded that SOC depends more on 
frontal lobe inputs. Again the epilepsy study presents nuances to this feature by 
revealing that several aspects of memory are of importance for normal function, also 
on SOC. As with other executive tests, SOC shows complexity and the frontal 
involvement is documented, hence we claim that SOC is a test of executive function.    
During this project we have gained clinical experience using CANTAB. The 
cognitive domains addressed seem relevant, but we claim that results reported should 
be those showing the highest reliability. Based on this we make the following 
recommendations for using CANTAB when assessing ICU survivors (table 7). These 
recommendations are based on cognitive domains of interest in the former ICU 
patient, test-retest correlations, time restrictions and the Jacksons criteria.  
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Table 7: Proposed CANTAB tests and reported results for investigating ICU patients 
CANTAB test/reported result Test-retest 
correlation 
coefficient, 
Lowe and 
Rabbitt 
Test-retest 
correlation 
coefficient, 
Camcog 
Approximate 
duration of test 
(minutes) 
ICU patients 
when Jackson 
criteria is 
applied  
Motor screening test (MOT)   3  
Mean latency    * 
Delayed matching to sample (DMS)   10  
Total correct, all delays  0.56 0.50  * 
Mean latency, 0 seconds     * 
Mean latency, 12 seconds     * 
Stockings of Cambridge (SOC)   10  
Problems solved in minimum moves, all  0.60 0.64  * 
Mean moves, 5 moves  0.47    
Mean initial thinking time   0.69  * 
Paired associate learning (PAL)   10  
Stages completed   0.87  * 
Total trails, adjusted 0.86   * 
1st trail memory score  0.68   * 
Intra-extra dimensional shift (IED)   7  
Stages completed   0.75   
Total errors to ED shift  0.70    
Reaction Time (RTI)   5  
Movement time  0.73  * 
Spatial span (SSP)   5  
Span 0.64 0.60   
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6. Conclusion 
1: Cambridge Neuropsychological Test Automated Battery is fully applicable in an 
intensive care setting and also in the follow-up of such patients. CANTAB can be 
administered by instructed ICU personnel.  
2: Three tests from the CANTAB battery (PAL, DMS, and SOC) are construct 
validated as well as cross test validated in Norwegian hospitalised patients showing 
that these tests target cognitive functions as previously described in other populations.  
3: Applied criteria for classification of cognitive impairment based on results from 
CANTAB proved relevant when approaching groups of critical illness survivors. 
4: Cognitive impairment is common after critical illness, both in cardiac arrest 
survivors and general ICU survivors.  
5: When interpreting differences between ICU patients on one side and CA patients 
and post surgical patients on the other, it is possible to claim that cognitive 
impairment in general ICU survivors not only are caused by cerebral hypoxia, but 
other factors in critical illness contribute as well. Impairment caused by such 
influence seems more likely to resolve.  
6: We found no associations between cognitive impairments after critical illness and 
mortality, institutionalisation or HRQOL. We cannot therefore conclude that 
cognitive impairments is without consequences since we have not evaluated other 
adverse outcomes such as hospital length of stay, costs, employment status, 
functional status or dependency on social benefits.   
7: ICU related cognitive impairments seem to resolve spontaneously in most patients. 
MMSE can be used to diagnose patients with severe cognitive impairments.  
8: Our findings confirm complex affection of cognition after critical illness, but we 
did not find a specific pattern in cognitive impairment in our patients.  
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7. Further research  
Brain dysfunction has been addressed in several patient populations. Postoperative 
cognitive decline has been thoroughly investigated [87-89] and cognitive impairment 
after cardiac arrest has also been described in detail [38, 48, 90]. The documentation 
of cognitive impairment after critical illness is not yet as systematic as for POCD or 
CA even though conditions such as ARDS and sepsis have been explored thoroughly 
and several studies also describe cognition in general ICU cohorts. Our study on ICU 
patients is only one way to approach this group. In the future information on other 
specific groups such as trauma patients or head injury patients could reveal more 
knowledge. It is possible to include matched control groups for all these conditions 
by investigating patients with the same condition but without need of treatment in an 
ICU.  
Given the already documented knowledge of the role of pre-ICU functional level and 
pre-ICU level of cognitive function further research within this field should include 
gathering information of these aspects in patients before admission to the ICU. 
Further follow-up of the ICU patients should include information of employment 
status, dependency of social benefits and activities of daily life as described in post-
CA cohorts [38]. Cognitive impairments, which do not seem to affect mortality, may 
affect these aspects of life. 
As emphasised by other authors international multi-centre studies with inclusion of 
large groups of patients (>1000) could aid in retrieving more knowledge of risk 
factors and also of consequences of even cognitive impairments. This may again help 
us to develop better prognostic tools and prophylactic interventions.  
One field of interest would be to explore which patients will develop permanent 
cognitive impairment and at which point of time during the post-ICU period the 
cognitive impairment must be regarded permanent. If this is revealed, efforts to 
prevent cognitive impairment could be targeted more precisely and perhaps more 
efficiently. In addition it would be easier to isolate the patients likely in need of 
cognitive rehabilitation and hence also easier to plan care after ICU or hospital 
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discharge. In the future randomised clinical trials focusing on cognitive intervention 
or rehabilitation could reveal potential positive benefits of such attempts.   
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